TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 277 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,000 | +500.0% | 903 | +622.4% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -66.7% | 125 | -63.9% | 0.00% | – |
| Q3 2020 | $6,000 | -85.0% | 346 | -84.4% | 0.00% | -100.0% |
| Q2 2020 | $40,000 | +900.0% | 2,213 | +647.6% | 0.00% | – |
| Q1 2020 | $4,000 | -55.6% | 296 | -37.9% | 0.00% | – |
| Q4 2019 | $9,000 | -78.0% | 477 | -79.8% | 0.00% | -100.0% |
| Q3 2019 | $41,000 | +5.1% | 2,366 | +6.6% | 0.00% | 0.0% |
| Q2 2019 | $39,000 | -69.5% | 2,220 | -64.7% | 0.00% | -75.0% |
| Q1 2019 | $128,000 | – | 6,282 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 7,584,930 | $138,046,000 | 26.79% |
| Glenview Capital Management | 15,260,512 | $277,741,000 | 6.37% |
| Paulson & Co. | 11,295,846 | $205,584,000 | 5.34% |
| GMT CAPITAL CORP | 2,871,395 | $52,259,000 | 3.72% |
| MANAGED ASSET PORTFOLIOS, LLC | 966,643 | $17,593,000 | 3.09% |
| TFG Asset Management GP Ltd | 1,443,052 | $26,264,000 | 1.76% |
| Mondrian Investment Partners LTD | 3,274,660 | $58,944,000 | 1.46% |
| Blackcrane Capital, LLC | 35,236 | $641,000 | 1.26% |
| Lumbard & Kellner, LLC | 136,378 | $2,404,000 | 0.95% |
| DAVIDSON INVESTMENT ADVISORS | 509,800 | $9,278,000 | 0.86% |